Natural small-molecule enhancers of autophagy induce autophagic cell death in apoptosis-defective cells

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Law, Betty Yuen Kwan ^a   Chan, Wai Kit ^a   Xu, Su Wei ^a   Wang, Jing Rong ^a   Bai, Li Ping ^a   Liu, Liang ^a   Wong, Vincent Kam Wai ^a  

^a MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID;

APOPTOSIS; AUTOPHAGY; CHEMISTRY; DRUG EFFECTS; HELA CELL LINE; HUMAN; MOLECULAR WEIGHT; PHYSIOLOGY;

ALKALOIDS; APOPTOSIS; AUTOPHAGY; HELA CELLS; HUMANS; MOLECULAR WEIGHT;

EID: 84903702024     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05510     Document Type: Article

References (58)

1. Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell 132, 27-42 (2008).
2. Pallauf, K. & Rimbach,G. Autophagy, polyphenols and healthy ageing. Ageing Res Rev 12, 237-252 (2013).
3. Sui, X. et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis 4, e838 (2013).
4. Mathew, R. et al. Autophagy suppresses tumor progression by l (Pubitemid 46871040)
5. Liang, X. H. et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402, 672-676 (1999). (Pubitemid 129516338)
6. Law, B. Y. et al. Alisol B, a novel inhibitor of the sarcoplasmic/ endoplasmic reticulum Ca(21) ATPase pump, induces autophagy, endoplasmic reticulum stress, and apoptosis. Mol Cancer Ther 9, 718-730 (2010).
7. Kondo, Y., Kanzawa, T., Sawaya, R. & Kondo, S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5, 726-734 (2005). (Pubitemid 41486365)
8. Hoyer-Hansen,M., Bastholm, L., Mathiasen, I. S., Elling, F. & Jaattela, M. Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death. Cell Death Differ 12, 1297-1309 (2005). (Pubitemid 41486100)
9. Chow, S. E., Chen, Y. W., Liang, C. A., Huang, Y. K. & Wang, J. S. Wogonin induces cross-regulation between autophagy and apoptosis via a variety of Akt pathway in human nasopharyngeal carcinoma cells. J Cell Biochem 113, 3476-3485 (2012).
10. Kandaswami, C. et al. The antitumor activities of flavonoids. In Vivo 19, 895-909 (2005).
11. Verschooten, L. et al. Autophagy inhibitor chloroquine enhanced the cell death inducing effect of the flavonoid luteolin in metastatic squamous cell carcinoma cells. PLoS One 7, e48264 (2012).
12. Mai, T. T. et al. Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells. Cancer Lett 321, 144-153 (2012).
13. Acharya, B. R., Bhattacharyya, S., Choudhury, D. & Chakrabarti, G. The microtubule depolymerizing agent naphthazarin induces both apoptosis and autophagy in A549 lung cancer cells. Apoptosis 16, 924-939 (2011).
14. Kuo, P. L., Hsu, Y. L. & Cho, C. Y. Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells. Mol Cancer Ther 5, 3209-3221 (2006).
15. Lu, J. J., Bao, J. L., Chen, X. P., Huang, M. & Wang, Y. T. Alkaloids isolated from natural herbs as the anticancer agents. Evid Based Complement Alternat Med 485042 (2012).
16. Wang, N. et al. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem 111, 1426-1436 (2010).
17. Meng, L. H. et al. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-Sspecific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res 64, 9086-9092 (2004).
18. Li, W. et al. BM6, a new semi-synthetic vinca alkaloid, exhibits its potent in vivo anti-tumor activities via its high binding affinity for tubulin and improved pharmacokinetic profiles. Cancer Biol Ther 6, 787-794 (2007). (Pubitemid 47328363)
19. Huang, M. et al. Chimmitecan, a novel 9-substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo. Clin Cancer Res 13, 1298-1307 (2007). (Pubitemid 46424071)
20. Lu, K., Yap, H. Y. & Loo, T. L. Clinical pharmacokinetics of vinblastine by continuous intravenous infusion. Cancer Res 43, 1405-1408 (1983). (Pubitemid 13160076)
21. Grossman, S.A. et al. Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas. Neuro Oncol 10, 608-616 (2008).
22. Wong, V. K., Zhou, H., Cheung, S. S., Li, T. & Liu, L. Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation. J Cell Biochem 107, 303-315 (2009).
23. Wong, V. K. et al. Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells. Cell Death Dis 4, e720 (2013).
24. Mizushima, N. & Yoshimori, T. How to interpret LC3 immunoblotting. Autophagy 3, 542-545 (2007). (Pubitemid 350060049)
25. Wu, A. G. et al. Onjisaponin B Derived from Radix Polygalae Enhances Autophagy and Accelerates the Degradation of Mutant alpha-Synuclein and Huntingtin in PC-12 Cells. Int J Mol Sci 14, 22618-22641 (2013).
26. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8, 445-544 (2012).
27. Bjorkoy, G. et al. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol 452, 181-197 (2009).
28. Kimura, S., Noda, T. & Yoshimori, T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3, 452-460 (2007). (Pubitemid 47293726)
29. Zhou, C. et al. Monitoring autophagic flux by an improved tandem fluorescenttagged LC3 (mTagRFP-mWasabi-LC3) reveals that high-dose rapamycin impairs autophagic flux in cancer cells. Autophagy 8, 1215-1226 (2012).
30. Seglen, P. O. & Gordon, P. B. 3-Methyladenine: specific inhibitor of autophagic/ lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A 79, 1889-1892 (1982). (Pubitemid 12088533)
31. Mizushima, N. & Klionsky, D. J. Protein turnover via autophagy: implications for metabolism. Annu Rev Nutr 27, 19-40 (2007). (Pubitemid 351373346)
32. Shaw, R. J. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol (Oxf) 196, 65-80 (2009).
33. Balgi, A. D. et al. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS One 4, e7124 (2009).
34. Komatsu, M. et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 169, 425-434 (2005). (Pubitemid 40686693)
35. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000). (Pubitemid 30046295)
36. Alva, A. S., Gultekin, S. H. & Baehrecke, E. H. Autophagy in human tumors: cell survival or death? Cell Death Differ 11, 1046-1048 (2004). (Pubitemid 39232364)
37. Mizushima, N., Levine, B., Cuervo, A. M. & Klionsky, D. J. Autophagy fights disease through cellular self-digestion. Nature 451, 1069-1075 (2008). (Pubitemid 351317450)
38. Wong,V. K. et al. Saikosaponin-d Enhances the Anticancer Potency of TNF-alpha via Overcoming Its Undesirable Response of ActivatingNF-Kappa B Signalling in Cancer Cells. Evid Based Complement Alternat Med, 745295 (2013).
39. Seto, B. Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer. Clin Transl Med 1, 29 (2012).
40. Chan, S. Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer. Br J Cancer 91, 1420-1424 (2004). (Pubitemid 39486341)
41. Xu, H. D. et al. The pro-survival role of autophagy depends on Bcl-2 under nutrition stress conditions. PLoS One 8, e63232 (2013).
42. Williams, A. et al. Novel targets for Huntington's disease in an mTORindependent autophagy pathway. Nat Chem Biol 4, 295-305 (2008). (Pubitemid 351550888)
43. Zhang, L. et al. Small molecule regulators of autophagy identified by an imagebased high-throughput screen. Proc Natl Acad SciUS A104, 19023-19028 (2007).
44. Maiuri, M. C., Zalckvar, E., Kimchi, A. & Kroemer, G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8, 741-752 (2007). (Pubitemid 47312826)
45. Lakhani, S. A. et al. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311, 847-851 (2006). (Pubitemid 43228848)
46. Friesen, C. et al. DNA-ligase IV and DNA-protein kinase play a critical role in deficient caspases activation in apoptosis-resistant cancer cells by using doxorubicin. Mol Biol Cell 19, 3283-3289 (2008).
47. Liang, Y., Yan, C. & Schor, N. F. Apoptosis in the absence of caspase 3. Oncogene 20, 6570-6578 (2001). (Pubitemid 32980283)
48. Guo, X. X. et al. Ginsenoside rh2 induces human hepatoma cell apoptosisvia bax/ bak triggered cytochrome C release and caspase-9/caspase-8 activation. Int J Mol Sci 13, 15523-15535 (2012).
49. Xavier, C. P. et al. Ursolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cells. J Nutr Biochem 24, 706-712 (2013).
50. Torricelli, C. et al. Alternative Pathways of Cancer Cell Death by Rottlerin: Apoptosis versus Autophagy. Evid Based Complement Alternat Med, 980658 (2012).
51. Hau, A. M. et al. Coibamide A induces mTOR-independent autophagy and cell death in human glioblastoma cells. PLoS One 8, e65250 (2013).
52. Zhou, H., Jiang, H., Yao, T. & Zeng, S. Fragmentation study on the phenolic alkaloid neferine and its analogues with anti-HIV activities by electrospray ionization tandem mass spectrometry with hydrogen/deuterium exchange and its application for rapid identification of in vitro microsomal metabolites of neferine. Rapid Commun Mass Spectrom 21, 2120-2128 (2007). (Pubitemid 46999266)
53. Dong, Z. X. et al. Comparative effects of liensinine and neferine on the human ether-a-go-go-related gene potassium channel and pharmacological activity analysis. Cell Physiol Biochem 29, 431-442 (2012).
54. Xiao, J. H., Zhang, J. H., Chen, H. L., Feng, X. L. & Wang, J. L. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice. Planta Med 71, 225-230 (2005).
55. Tian, Y. et al. The interaction between human breast cancer resistance protein (BCRP) and five bisbenzylisoquinoline alkaloids. Int J Pharm 453, 371-379 (2013).
56. Yang, Z. et al. Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells. J Cell Physiol 225, 266-275 (2010).
57. Rogosnitzky, M. & Danks, R. Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions. Pharmacol Rep 63, 337-347 (2011).
58. Malofeeva, E. V., Domanitskaya, N., Gudima, M. & Hopper-Borge, E. A. Modulation of the ATPase and transport activities of broad-acting multidrug resistance factor ABCC10 (MRP7). Cancer Res 72, 6457-6467 (2012).